$16.37
-0.49-2.91%
Last update: Nov 10, 5:06 AM
Jasper Therapeutics Inc
JSPRNASDAQ
Jasper Therapeutics rose 819.7% from $1.78 to $16.37, ahead of the S&P 500's +10.5%. Its worst day was Jun 1 (−35.6%), and its low came Jun 26 at $0.34.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-1.13 beat the $-1.18 estimate on $0.00 revenue.
0.0% · S&P 500 +1.6%
EPS of $-0.32 beat the $-0.81 estimate on $0.00 revenue.
Story events cover the past 12 months · Times ET
−2.6% · S&P 500 +2.9%
EPS of $-0.04 beat the $-0.52 estimate on $0.00 revenue.
−11.4% · S&P 500 −1.2%
Jasper Therapeutics closed at its lowest level of the year, 80.8% below where the year started.
−23.0% · S&P 500 −0.7%
EPS of $-0.10 beat the $-0.52 estimate on $0.00 revenue.
−8.5% · S&P 500 −0.2%
Where it ended: a close of $16.37 on Nov 9, 2026. Up next: Q3 2026 earnings on Nov 24, 2026 (EPS est. $-0.46, revenue est. $4.3M).
Nothing in the past 12 months.
All JSPR dividend historyReplay the year: the line draws itself and stops at each of the 5 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for JSPR and SPY from Benzinga historical bars. Not investment advice.
